[Clinical experiences with Dibromdulcitol (DBD) in the treatment of cancer].
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001772:Blood Cell Count; D001966:Bromine / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000401:mortality; D004376:Galactitol / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D013402:Sugar Alcohols / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013402:Sugar Alcohols; D004376:Galactitol; D001966:Bromine
Expériences cliniques avec Dibromdulcite (DBD) dans le traitement du cancer bronchique.